Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

DSFIR FINANCIAL STATEMENTS

DSM-Firmenich AG — balance sheet, income statement and cash flow trends

DSFIRDSM-Firmenich AG

🇳🇱 Netherlands · AS · Basic Materials · Specialty Chemicals

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
05 B10 B202020212022202320242025

Profit Funnel

Q3 2025 · TTM
Revenue12.3 B €Gross Profit4.8 B € · 39%Operating Income1.1 B € · 9%Pre-tax Income619 M € · 5%Net Income-977 M € · -8%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue12.3 B €-2.7%
Gross Profit4.8 B €+25.5%
Operating Income1.1 B €+285.1%
EBITDA2.2 B €+78.0%
Net Income-977 M €-3,356.7%

Peer Comparison· Specialty Chemicals

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
DSFIR-2.7%39.0%18.2%-8.0%
PPG10.0%40.6%17.6%9.8%
IFF-5.6%36.3%18.5%7.9%
LYB-13.9%9.7%4.4%-2.7%
ALB7.9%18.5%13.6%-4.2%
RPM5.7%41.4%14.9%8.6%
Industry median1.2%26.7%14.7%3.5%
CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
DSFIR-2.7%39.0%18.2%-8.0%
AKZA-7.0%40.1%16.0%6.3%
IMCD1.2%17.7%10.9%4.5%
Industry median1.2%26.7%14.7%3.5%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B202020212022202320242025

Capital Structure

Q3 2025
Total Assets29.3 B
  • Equity18.2 B €63%
  • Current Liabilities5.6 B €19%
  • Long-term Liabilities5.3 B €18%

Key Figures

YoY change
Total Assets29.3 B €-13.0%
Total Liabilities10.9 B €-1.2%
Total Equity18.2 B €-19.0%
Cash & ST Investments1.9 B €-30.0%
Total Debt5.3 B €-0.1%
Net Debt3.5 B €+33.8%

Peer Comparison· Specialty Chemicals

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
DSFIR1.5928.9%1.5162.2%
PPG1.6195.4%2.1536.6%
IFF1.4941.2%2.6356.2%
LYB1.54142.0%8.8429.6%
ALB2.0719.1%1.0665.1%
RPM2.2892.1%2.2739.9%
Industry median1.8763.0%2.1546.9%
CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
DSFIR1.5928.9%1.5162.2%
AKZA1.72125.2%1.9431.5%
IMCD1.7383.4%2.8144.0%
Industry median1.8763.0%2.1546.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
01 B2 B202020212022202320242025

Cash Flow Bridge

Q3 2025 · TTM
01 B2 B2.1 B €Operating493.5 M €Investing-2.5 B €Financing50.5 M €Net Change

Key Figures

YoY change
Operating Cash Flow2.1 B €+27.1%
Capital Expenditures918 M €+36.6%
Free Cash Flow1.1 B €+20.3%
Dividends Paid-717 M €-188.5%

Peer Comparison· Specialty Chemicals

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
DSFIR16.7%9.2%7.5%-210.0%
PPG12.4%7.6%4.7%125.7%
IFF9.1%3.7%5.4%115.0%
LYB8.7%9.4%8.9%-324.3%
ALB19.7%10.5%9.2%-465.1%
RPM10.4%7.5%3.0%121.0%
Industry median9.6%5.8%5.0%111.7%
CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
DSFIR16.7%9.2%7.5%-210.0%
AKZA9.6%6.6%3.0%153.9%
IMCD6.7%6.5%0.3%148.1%
Industry median9.6%5.8%5.0%111.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DSFIR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.